XM_017011233.2:c.59G>A

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 1P and 18B. PP2BP4_ModerateBP6_Very_StrongBA1

The XM_017011233.2(TFAP2B):​c.59G>A​(p.Ser20Asn) variant causes a missense change. The variant allele was found at a frequency of 0.126 in 1,600,400 control chromosomes in the GnomAD database, including 15,106 homozygotes. In-silico tool predicts a benign outcome for this variant. 4/5 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2795 hom., cov: 32)
Exomes 𝑓: 0.12 ( 12311 hom. )

Consequence

TFAP2B
XM_017011233.2 missense

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 6.23

Publications

21 publications found
Variant links:
Genes affected
TFAP2B (HGNC:11743): (transcription factor AP-2 beta) This gene encodes a member of the AP-2 family of transcription factors. AP-2 proteins form homo- or hetero-dimers with other AP-2 family members and bind specific DNA sequences. They are thought to stimulate cell proliferation and suppress terminal differentiation of specific cell types during embryonic development. Specific AP-2 family members differ in their expression patterns and binding affinity for different promoters. This protein functions as both a transcriptional activator and repressor. Mutations in this gene result in autosomal dominant Char syndrome, suggesting that this gene functions in the differentiation of neural crest cell derivatives. [provided by RefSeq, Jul 2008]
TFAP2B Gene-Disease associations (from GenCC):
  • Char syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • TFAP2B-related congenital heart disease spectrum disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • patent ductus arteriosus 2
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • familial patent arterial duct
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript XM_017011233.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 8 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 1.2875 (below the threshold of 3.09). Trascript score misZ: 1.5192 (below the threshold of 3.09). GenCC associations: The gene is linked to familial patent arterial duct, Char syndrome, TFAP2B-related congenital heart disease spectrum disorder, patent ductus arteriosus 2.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 6-50818858-G-A is Benign according to our data. Variant chr6-50818858-G-A is described in ClinVar as Benign. ClinVar VariationId is 1273651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.286 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000393655.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TFAP2B
NM_003221.4
MANE Select
c.-34G>A
upstream_gene
N/ANP_003212.2Q92481-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TFAP2B
ENST00000344788.7
TSL:3
c.-67G>A
5_prime_UTR
Exon 1 of 4ENSP00000342252.3X6R4Y8
ENSG00000297125
ENST00000745639.1
n.343+44C>T
intron
N/A
TFAP2B
ENST00000393655.4
TSL:1 MANE Select
c.-34G>A
upstream_gene
N/AENSP00000377265.2Q92481-1

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26273
AN:
151822
Hom.:
2792
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.291
Gnomad AMI
AF:
0.0681
Gnomad AMR
AF:
0.145
Gnomad ASJ
AF:
0.176
Gnomad EAS
AF:
0.208
Gnomad SAS
AF:
0.192
Gnomad FIN
AF:
0.192
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.102
Gnomad OTH
AF:
0.169
GnomAD2 exomes
AF:
0.149
AC:
37476
AN:
250704
AF XY:
0.149
show subpopulations
Gnomad AFR exome
AF:
0.295
Gnomad AMR exome
AF:
0.118
Gnomad ASJ exome
AF:
0.171
Gnomad EAS exome
AF:
0.228
Gnomad FIN exome
AF:
0.187
Gnomad NFE exome
AF:
0.105
Gnomad OTH exome
AF:
0.154
GnomAD4 exome
AF:
0.122
AC:
176025
AN:
1448460
Hom.:
12311
Cov.:
28
AF XY:
0.123
AC XY:
88848
AN XY:
721588
show subpopulations
African (AFR)
AF:
0.299
AC:
9910
AN:
33184
American (AMR)
AF:
0.121
AC:
5423
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
4345
AN:
26054
East Asian (EAS)
AF:
0.226
AC:
8936
AN:
39618
South Asian (SAS)
AF:
0.189
AC:
16276
AN:
85952
European-Finnish (FIN)
AF:
0.175
AC:
9327
AN:
53158
Middle Eastern (MID)
AF:
0.163
AC:
937
AN:
5740
European-Non Finnish (NFE)
AF:
0.102
AC:
112690
AN:
1100116
Other (OTH)
AF:
0.136
AC:
8181
AN:
59948
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
7736
15471
23207
30942
38678
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4428
8856
13284
17712
22140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.173
AC:
26288
AN:
151940
Hom.:
2795
Cov.:
32
AF XY:
0.179
AC XY:
13294
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.290
AC:
12013
AN:
41382
American (AMR)
AF:
0.146
AC:
2230
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.176
AC:
611
AN:
3470
East Asian (EAS)
AF:
0.207
AC:
1068
AN:
5154
South Asian (SAS)
AF:
0.192
AC:
920
AN:
4802
European-Finnish (FIN)
AF:
0.192
AC:
2028
AN:
10558
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.102
AC:
6955
AN:
67978
Other (OTH)
AF:
0.168
AC:
354
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1051
2102
3153
4204
5255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.132
Hom.:
3401
Bravo
AF:
0.175
Asia WGS
AF:
0.182
AC:
632
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Char syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
21
DANN
Benign
0.93
PhyloP100
6.2
PromoterAI
0.042
Neutral
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2272903;
hg19: chr6-50786571;
COSMIC: COSV53831805;
COSMIC: COSV53831805;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.